Discover hundreds of clinical trials in Wisconsin.
Search clinical trials in Wisconsin by city, condition or phase.
The state of Wisconsin offers a substantial healthcare network and renowned medical research institutions, making it a prime location for clinical research into a variety of conditions. Leading centers such as the University of Wisconsin School of Medicine and Public Health, the Medical College of Wisconsin, and Froedtert Hospital are state leaders in medical research. These institutions, known for their innovative approaches, provide a strong foundation for conducting clinical trials that advance medical knowledge and treatment options.
There are several reasons why researchers conduct clinical trials in Wisconsin. Firstly, the state’s diverse population provides a wide range of participants, which enhances the accuracy and applicability of research outcomes. Wisconsin is also home to a thriving research community, with a strong emphasis on medical innovation and innovative studies that push boundaries.
By choosing to participate in a clinical trial in Wisconsin, you play a crucial role in advancing medical research while benefiting from a well-established and supportive clinical research environment, backed by renowned institutions and expert healthcare professionals.
The state of Wisconsin is recognized for its contributions to clinical research in several key medical fields.
The Children’s Hospital of Wisconsin is a leader in pediatric research, conducting clinical trials on a variety of childhood diseases. Trials cover conditions like cystic fibrosis, where researchers test new treatments aimed at improving lung function and overall health.
Studies also focus on managing asthma through innovative inhalers and medications, and genetic disorders, where gene therapies and new diagnostic techniques are explored to provide better outcomes for children.
Cardiovascular health is a significant concern in Wisconsin, prompting extensive research into heart disease. Major institutions like the Medical College of Wisconsin lead clinical trials on new pharmacological treatments, lifestyle modifications, and interventional procedures aimed at reducing heart disease risk.
Studies often investigate the effectiveness of medical devices such as stents and pacemakers, and research into preventive measures is critical, given the high prevalence of obesity and hypertension in the region.
Wisconsin’s research into diabetes addresses both Type 1 and Type 2 diabetes, focusing on developing innovative insulin therapies and oral medications that enhance glycemic control.
Trials often involve lifestyle interventions, such as diet and exercise programs, to evaluate their effectiveness in managing blood sugar levels. Additionally, researchers explore the genetic and environmental factors contributing to diabetes prevalence, aiming to improve preventive strategies.
The state of Wisconsin is a hub for research into neurological disorders, particularly at the Wisconsin Alzheimer’s Disease Research Center. Clinical trials aim to discover new drugs to slow disease progression in Alzheimer’s and Parkinson’s patients, as well as approaches to enhance cognitive function. Research also investigates biomarkers for early diagnosis and the potential benefits of lifestyle modifications, such as exercise and diet, in managing neurological health.
Wisconsin's focus on autoimmune diseases includes extensive research into rheumatoid arthritis, lupus, and multiple sclerosis (MS). Clinical trials test new biologic agents that target specific immune pathways to reduce inflammation and disease symptoms.
The state’s medical institutions also explore the psychosocial aspects of living with chronic autoimmune conditions, aiming to develop comprehensive care strategies that address both physical and emotional well-being.
Wisconsin's commitment to cancer research is exemplified by the University of Wisconsin Carbone Cancer Center, which is recognized for its innovative approaches to treating various cancer types. Ongoing oncology clinical trials here explore novel therapies, including immunotherapies that harness the body’s immune system to fight cancer, and targeted therapies that aim to attack specific cancer cells.
Research in Wisconsin also focuses on improving early detection methods and enhancing patient quality of life during treatment. These efforts are crucial in a state where cancer remains a leading cause of death.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
In Wisconsin, clinical trials are governed by a combination of federal and state regulations that ensure participant safety and good ethical conduct. The primary regulatory body is the U.S. Food and Drug Administration (FDA), which oversees clinical trial protocols, informed consent, and the use of investigational drugs. Additionally, all research involving human subjects must comply with the guidelines established by the Institutional Review Boards (IRBs) at the participating institutions.
Wisconsin also adheres to the Common Rule, a federal policy that sets standards for the ethical treatment of research subjects, including requirements for informed consent and monitoring of ongoing studies.
State laws may impose additional protections, especially for vulnerable populations such as minors or individuals with diminished capacity. Researchers must also register their trials on ClinicalTrials.gov, providing transparency and access to information for potential participants.
Volunteering in a clinical trial presents a valuable chance for individuals to experience innovative treatments and therapies before they become widely accessible. This is particularly important for those whose conditions have not improved with standard medical interventions. During the trial, participants benefit from the expertise of dedicated healthcare professionals who provide tailored care and rigorous monitoring, ensuring both safety and effectiveness throughout the process.
Moreover, involvement in clinical trials is essential for the progress of medical research. These studies frequently result in significant advancements in treatment methodologies and health strategies. By participating, individuals not only gain early access to transformative care but also play a crucial role in advancing scientific knowledge, ultimately influencing the future of healthcare and enhancing outcomes for patients everywhere.
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
Sponsor:
Checkpoint Surgical Inc.
Location:
Code:
NCT04662320
Conditions
Cubital Tunnel Syndrome
Nerve Compression
Nerve Injury
Ulnar Neuropathies
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Checkpoint BEST System
Sponsor:
Grifols Therapeutics LLC
Location:
Code:
NCT03702920
Conditions
Acute-On-Chronic Liver Failure
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
SMT + PE-A 5%
Standard Medical Treatment
Sponsor:
Johns Hopkins University
Location:
Code:
NCT05537220
Conditions
Retinitis Pigmentosa
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
N-acetylcysteine
Placebo
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT03155620
Conditions
Advanced Malignant Solid Neoplasm
Ann Arbor Stage III Non-Hodgkin Lymphoma
Ann Arbor Stage IV Non-Hodgkin Lymphoma
Histiocytic Sarcoma
Juvenile Xanthogranuloma
Eligibility Criteria
Sex: All
Age: 12 - 21
Healthy Volunteers: Not accepted
Interventions
Biopsy
Biospecimen Collection
Bone Marrow Aspiration and Biopsy
Bone Scan
Computed Tomography
Sponsor:
Biogen
Location:
Code:
NCT05798520
Conditions
Relapsing Forms of Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
BIIB091
DRF
Placebo
Sponsor:
Novo Nordisk A/S
Location:
Code:
NCT06131372
Conditions
Chronic Kidney Disease
Type 2 Diabetes
Obesity
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cagrilintide
Semaglutide
Placebo
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05276973
Conditions
Fallopian Tube Endometrioid Adenocarcinoma
Fallopian Tube High Grade Serous Adenocarcinoma
Ovarian Endometrioid Adenocarcinoma
Ovarian High Grade Serous Adenocarcinoma
Primary Peritoneal Endometrioid Adenocarcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy
Carboplatin
Ipatasertib
Paclitaxel
Sponsor:
Gilead Sciences
Location:
Code:
NCT03547973
Conditions
Metastatic Urothelial Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Sacituzumab Govitecan-hziy
Pembrolizumab
Cisplatin
Avelumab
Zimberelimab
Sponsor:
NRG Oncology
Location:
Code:
NCT04134260
Conditions
Prostate Adenocarcinoma
Stage I Prostate Cancer AJCC v8
Stage II Prostate Cancer AJCC v8
Stage IIA Prostate Cancer AJCC v8
Stage IIB Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Apalutamide
Hormone Therapy
Quality-of-Life Assessment
Questionnaire Administration
Radiation Therapy